Potent antisera of high specificity and sensitivity were produced, in goats, to purified Australia antigen (Au). 
munodiffusion in agar gel and discontinuous counterimmunoelectrophoresis (DCIE) as well as specific complement-fixing antibody and could be used for routine screening of sera for Au without prior adsorption with Au-negative normal human serum (NHS) . Identification of 66 of 70 positive specimens (94.3%) in a panel of 98 coded sera (49 duplicates) with 100% reproducibility was made by using one of the goat anti-Au sera at a dilution of 1:16 in the DCIE method. No false positives were recorded. Low levels of antibody against NHS components were effectively removed by a single adsorption with glutaraldehyde cross-linked NHS. Since the original observations that a unique antigen, termed Australia antigen (Au), was closely associated with long-incubation-type viral hepatitis type B (2, 7, 13) , a number of reports have appeared on methodology applicable to the detection of Au. The techniques (8) include immunodiffusion in agar gel (AGD), complement-fixation (CF), counterimmunoelectrophoresis (CIE), passive hemagglutination (PHA), radioimmunoassay (RIA), immune electron microscopy and immunofluorescence. Effective utilization of these procedures is dependent on the availability of high-titered anti-Au sera. Initially, antisera were obtained from multiply transfused hemophiliac patients. However, the availability of this source has been limited, and, in most cases, because of low titer, these sera could be used only at low dilutions for routine screening of Au.
More recently, several reports have appeared on the production of anti-Au antibody in rabbits, guinea pigs, mice, and horses (3, 10, 12, 14) , which have been of limited value for one or more of the following reasons: limited quantity, low titers, anticomplementary activity or the requirement for extensive adsorption with normal human serum (NHS).
This report is concerned with: (i) procedures to purify Au effectively, (ii) production of hightiter antisera in goats, and (iii) adsorption of low levels of antibody directed toward NHS components by using insoluble immunoadsorbents.
MATERIALS AND M1ETHODS
Purification of Au. High-titer Au-positive plasma (CF titer 1:5,120) was obtained from an anicteric volunteer blood donor and purified by three different procedures, as follows (Fig. 1) activity was determined by CF, and the peak fractions were pooled. Procedure 2. Au was purified as described for procedure 1, with the exception that the acid treatment after the first pelleting was omitted (Fig. 1) .
Procedure 3. Au-positive serum (250 ml) was processed in a Spinco BXIV preparative rotor in a preformed CsCl gradient. Fractions having a density of 1.18 to 1.22 g/cm3 were pooled and recycled in a similar gradient. The Au-positive fractions were dialyzed against water to remove the CsCl and then against 0.05 M potassium phthalate buffer, pH 2.4, for 1 hr at 4 C. The Au was further purified by preparative Pevikon zonal electrophoresis with 0.05 M potassium phthalate buffer and electrophoresis fcr 10 hr at 400 v (4 C). Under these conditions, Au-positive material migrated toward the anode, 5 to 7 cm away from the origin, whereas the detectable protein as measured by the Folin reaction was present in fractions migrating 13 to 24 cm away from the origin. Electron microscope examination of representative negatively stained preparations obtained by each of the three methods yielded 22 i 2 nm particles free of background debris (Fig. 2) . The particle count ranged from 10's to 1014 per ml with a protein concentration of 70 to 200 ,g/ml, as determined by the Folin method (9) with crystalline bovine albumin as a standard. About 9 to 12 ml of purified material was obtained from procedures 1 and 2 and 16 to 20 ml from method 3.
Assessment of Au purity. Each preparation of purified Au was examined for contaminating NHS proteins by radioimmunoelectrophoresis (RIE) performed by the method previously described (4) . Briefly, a sample of each of the preparations used for immunization of goats was iodinated (6) , with the assumption that remaining serum proteins would label with the same efficiency as Au. Equal volumes of 125I-Au were mixed with either Au-positive serum or NHS. These preparations were subjected to electrophoresis, and precipitin bands developed with either anti-Au or anti-NHS sera. The line observed on the exposed X-ray film (Fig. 3 ) corresponded to the stained precipitin line observed between Au and anti-Au. In contrast, anti-NHS serum failed to coprecipitate any radioactive material. In addition, purified labeled Au contained no detectable NHS components when analyzed by the radioimmunoassay (RIA-DA) technique (6) . Further evaluation of the three different purified Au antigen preparations is presented below by analyzing the antibody response of goats hyperimmunized with each.
Immunization of goats. Two goats each were immunized with Au purified by each of the above methods. Equal volumes of purified Au (35 to 50 ,ug of protein per goat per immunization) and complete Freund's adjuvant were emulsified and inoculated intramuscularly into both flanks and both shoulders (1.0 ml/site). Injections were made on days 0, 14, and 25, and blood was drawn from the jugular vein on days 32, 39, and 56. On days 77 and 89, each of the goats was boosted intramuscularly with 35 ,ug of Au purified by method 1 with Freund's complete adjuvant.
Approximately 500 ml of blood was obtained from each goat on days 98 and 105. All goats were reinoculated on day 158 with material purified by procedure 1 and bled 10 days later (day 168).
Adsorption of antisera. Samples of goat anti-Au sera were adsorbed with an Au-negative NHS pool rendered insoluble by cross-linking with glutaraldehyde by the method described by Avrameas (Fig. 4) . (6) . No reactivity was observed with undiluted NHS. However, a reaction was observed between undiluted goat 2325 and NHS diluted to 1: 256. These contaminating antibodies were found to react with human albumin and immunoglobulin G (Fig. Sa) . Simi all reactivity to NHS components (Fig. 5d) but X~did not appreciably decrease the antibody titer for Au (Fig. 4, 5c ). It is noteworthy that the n adsorbed antisera did not become anticomplementary.
Sensitivity of goat anti-Au. A two-dimensional = titration by the DCIE method using two goat t antisera (2325 and 2327) against an Au-positive .= reference serum (H-368) is shown in Table 3 . Y Dilution of the goat antiserum in Veronal .~buffer, pH 8.6 (,=0.015), indicated that the high-= est antigen titer was obtained by using undiluted serum or a 1:2 serum dilution. However, when the antisera were diluted in undiluted preimmune O (or anti-Au-negative) goat serum, higher dilu-= tions of goat antisera could be used while maintaining the same degree of sensitivity (Table 3) .
. In a DCIE test against 98 coded sera (49 dupli- with Au derived from 120 ml of Au-positive serum, and 5 to 10 liters of high-titering anti-Au could be expected upon exsanguination of the goats. Procedure 3 could be used on a commercial basis to produce large amounts of purified antigen similar to that reported by Gerin et al. (5) by repeated zonal centrifugation, although greater contamination with NHS components occurred in this study. It is also of note that these goats have now been boosted with procedure 1-purified Au a total of four times with little loss of specificity. The specificity is such that it can be used for diagnostic purposes at dilutions at which NHS is not detectable by AGD, CIE, and CF.
The goat antisera produced in this study are suitable as diagnostic reagents by CF, since no anticomplementary activity was detected, unlike that previously observed for goat anti-Au sera (18) . On the basis of the very high precipitin titers produced, a higher reactivity would have been expected by the CF reaction. This lower sensitivity in the CF test is unexplained but could be related to poor fixation of guinea pig complement due to unique species differences or to loss of specific CF antigen during purification.
The low levels of anti-NHS present in these antisera were directed toward major serum proteins as evidenced by the two-dimensional CF titrations and by IE. Since these contaminating antibodies were observed after hyperimmunization, one must conclude that NHS proteins were present in the purified preparations at levels below the sensitivity of the RIA-DA and RIA methods employed. The importance of including an NHS control in CF screening of sera for Au is illustrated in Fig. 4 There appear to be several advantages in the use of insoluble immunoadsorbents to produce monospecific anti-Au sera. First, the contaminating antibodies can be effectively removed so that no soluble immune complexes remain. Consequently, such an adsorption provides antisera which are not anticomplementary in the CF reaction, and the possibility of elution of contaminating antibody from these soluble complexes is avoided. A second advantage is that antisera which have high levels of contaminating antibody can be adsorbed with large amounts of crosslinked NHS without dilution of the anti-Au sera. Thirdly, the phenomenon of detecting NHS components at high antigen dilutions is eliminated.
In this study, the goat antisera were rendered monospecific with whole insolubilized NHS since the anti-NHS antibodies were of low titer and directed against major NHS components. However, selection of specific proteins to prepare water-insoluble immunoadsorbents could be made after the specificity of the contaminating antibodies was defined. For instance, rabbit anti-Au produced in this laboratory against a partially purified Au preparation contained high levels of antibody against human alpha globulins. Thus, these antisera were more effectively adsorbed with cross-linked human alpha globulin (fraction IV, Pentex Biochemicals, Kankakee, Ill.), since the amount of alpha globulin in whole serum is relatively low.
Schmidt and Lennette (15) emphasized the importance of using optimal proportions of human anti-Au sera to assay Au by either CF or AGD in that an extensive "pro-zone" of inhibitory activity was observed. This phenomenon was confirmed when these potent goat antiAu were used as screening reagents for CF and AGD tests. The pro-zone effect was minimized as observed by DCIE testing if the goat anti-Au serum was diluted in normal goat serum. The INFECT. IMMUNITY stabilizing effect of the normal goat serum is under investigation.
It is noteworthy that these goat antisera and the guinea pig antisera used in this study both contained antibody directed toward serum albumin and immunoglobulin G. This is of particular concern in relationship to studies in which experimental antisera are utilized for immunofluorescence staining techniques. Detection of material in the liver, renal glomeruli, and arterial walls could possibly be due to the deposition of soluble antibody-antigen complexes unrelated to Au since experimental antisera may contain low levels of anti-immunoglobulin G antibody.
